Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020
Overview
Affiliations
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was first identified in December 2019 in Wuhan, China, and has since spread worldwide. On March 11, 2020, the World Health Organization declared COVID-19 a pandemic (1). That same day, the first confirmed COVID-19-associated fatality occurred in New York City (NYC). To identify confirmed COVID-19-associated deaths, defined as those occurring in persons with laboratory-confirmed SARS-CoV-2 infection, on March 13, 2020, the New York City Department of Health and Mental Hygiene (DOHMH) initiated a daily match between all deaths reported to the DOHMH electronic vital registry system (eVital) (2) and laboratory-confirmed cases of COVID-19. Deaths for which COVID-19, SARS-CoV-2, or an equivalent term is listed on the death certificate as an immediate, underlying, or contributing cause of death, but that do not have laboratory-confirmation of COVID-19 are classified as probable COVID-19-associated deaths. As of May 2, a total of 13,831 laboratory-confirmed COVID-19-associated deaths, and 5,048 probable COVID-19-associated deaths were recorded in NYC (3). Counting only confirmed or probable COVID-19-associated deaths, however, likely underestimates the number of deaths attributable to the pandemic. The counting of confirmed and probable COVID-19-associated deaths might not include deaths among persons with SARS-CoV-2 infection who did not access diagnostic testing, tested falsely negative, or became infected after testing negative, died outside of a health care setting, or for whom COVID-19 was not suspected by a health care provider as a cause of death. The counting of confirmed and probable COVID-19-associated deaths also does not include deaths that are not directly associated with SARS-CoV-2 infection. The objective of this report is to provide an estimate of all-cause excess deaths that have occurred in NYC in the setting of widespread community transmission of SARS-CoV-2. Excess deaths refer to the number of deaths above expected seasonal baseline levels, regardless of the reported cause of death. Estimation of all-cause excess deaths is used as a nonspecific measure of the severity or impact of pandemics (4) and public health emergencies (5). Reporting of excess deaths might provide a more accurate measure of the impact of the pandemic.
Maduro G, Li W, Huynh M, Bernard-Davila B, Gould L, Van Wye G BMJ Open. 2024; 14(4):e072441.
PMID: 38569678 PMC: 11146393. DOI: 10.1136/bmjopen-2023-072441.
Azofeifa A, Liu R, Dupont H, Reissman D Public Health Rep. 2024; 139(3):301-308.
PMID: 38298086 PMC: 11037234. DOI: 10.1177/00333549231223143.
Aune K, Grantz K, Prata Menezes N, Robsky K, Gurley E, Marx M Am J Epidemiol. 2023; 193(2):267-276.
PMID: 37715454 PMC: 10840074. DOI: 10.1093/aje/kwad186.
Zhang X, Kuliszewski M, Kahn A, Schymura M J Registry Manag. 2023; 49(4):170-176.
PMID: 37260816 PMC: 10229191.
Brief Report: Trends in HIV Mortality in the Context of the COVID-19 Pandemic.
Patterson W, Rosenthal M, Rajulu D J Acquir Immune Defic Syndr. 2023; 94(2):91-94.
PMID: 37220009 PMC: 10497194. DOI: 10.1097/QAI.0000000000003228.